Shuguang Pang Selected Research

Type 2 Diabetes Mellitus (MODY)

11/2023	Asprosin, a novel glucogenic adipokine implicated in type 2 diabetes mellitus.
10/2023	Fotagliptin monotherapy with alogliptin as an active comparator in patients with uncontrolled type 2 diabetes mellitus: a randomized, multicenter, double-blind, placebo-controlled, phase 3 trial.
1/2023	Pharmacokinetics, Pharmacodynamics and Safety of Janagliflozin in Chinese Type 2 Diabetes Mellitus Patients with Renal Impairment.
1/2023	Efficacy and safety of janagliflozin monotherapy in Chinese patients with type 2 diabetes mellitus inadequately controlled on diet and exercise: A multicentre, randomized, double-blind, placebo-controlled, Phase 3 trial.
1/2023	Efficacy and safety of janagliflozin as add-on therapy to metformin in Chinese patients with type 2 diabetes inadequately controlled with metformin alone: A multicentre, randomized, double-blind, placebo-controlled, phase 3 trial.
1/2022	A phase 1b randomised controlled trial of a glucagon-like peptide-1 and glucagon receptor dual agonist IBI362 (LY3305677) in Chinese patients with type 2 diabetes.
8/2021	Correction to: Efficacy and safety of PEGylated exenatide injection (PB-119) in treatment-naive type 2 diabetes mellitus patients: a Phase II randomised, double-blind, parallel, placebo-controlled study.
1/2021	Efficacy and safety of PEGylated exenatide injection (PB-119) in treatment-naive type 2 diabetes mellitus patients: a Phase II randomised, double-blind, parallel, placebo-controlled study.
1/2019	A Possible Mechanism of Metformin in Improving Insulin Resistance in Diabetic Rat Models.
12/2017	Metformin affects thyroid function in male rats.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shuguang Pang Research Topics

Disease

13	Type 2 Diabetes Mellitus (MODY) 11/2023 - 01/2014
8	Insulin Resistance 11/2023 - 01/2014
7	Body Weight (Weight, Body) 12/2023 - 01/2013
3	Obesity 12/2023 - 12/2015
3	Hyperglycemia 10/2023 - 01/2013
2	Nausea 12/2023 - 01/2022
1	Hyperphagia (Overeating) 12/2023
1	Overweight 12/2023
1	Respiratory Tract Infections (Respiratory Tract Infection) 12/2023
1	Hyperlipidemias (Hyperlipidemia) 10/2023
1	Hypoglycemia (Reactive Hypoglycemia) 10/2023
1	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2023
1	Metabolic Diseases (Metabolic Disease) 01/2022
1	Hypertriglyceridemia 01/2022
1	Birth Weight (Birth Weights) 05/2021
1	Weight Gain 05/2021
1	Rupture 05/2021
1	Gestational Diabetes (Gestational Diabetes Mellitus) 05/2021
1	Hepatocellular Carcinoma (Hepatoma) 01/2021
1	Hyperthyroidism 12/2017
1	Diarrhea 12/2017
1	Thyroid Neoplasms (Thyroid Cancer) 01/2017
1	Glucose Intolerance 01/2014
1	Diabetes Mellitus 01/2014
1	Unconsciousness (Loss of Consciousness) 12/2013
1	Dumping Syndrome (Syndrome, Dumping) 12/2013

Drug/Important Bio-Agent (IBA)

9	Glucose (Dextrose)FDA LinkGeneric 11/2023 - 01/2013
9	Metformin (Glucophage)FDA LinkGeneric 10/2023 - 01/2015
3	HDL CholesterolIBA 01/2023 - 01/2013
3	janagliflozinIBA 01/2023 - 01/2023
3	Bile Acids and Salts (Bile Acids)IBA 12/2015 - 01/2014
2	mazdutideIBA 12/2023 - 01/2022
2	Streptozocin (Streptozotocin)FDA Link 10/2023 - 01/2019
2	fibroblast growth factor 21IBA 10/2023 - 05/2017
2	Exenatide (Byetta)FDA Link 08/2021 - 01/2021
2	Triglycerides (Triacylglycerol)IBA 05/2021 - 01/2013
2	Blood Glucose (Blood Sugar)IBA 05/2021 - 12/2015
2	CholesterolIBA 12/2015 - 01/2013
2	Simvastatin (Zocor)FDA LinkGeneric 01/2014 - 01/2013
1	AdipokinesIBA 11/2023
1	fotagliptinIBA 10/2023
1	alogliptinIBA 10/2023
1	Dipeptidyl-Peptidase IV InhibitorsIBA 10/2023
1	SodiumIBA 01/2023
1	C-PeptideIBA 01/2023
1	HDL LipoproteinsIBA 01/2023
1	dulaglutideIBA 01/2022
1	Glucagon Receptors (Glucagon Receptor)IBA 01/2022
1	X-Box Binding Protein 1IBA 01/2022
1	Diacylglycerol O-AcyltransferaseIBA 01/2022
1	AMP-Activated Protein KinasesIBA 01/2022
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2022
1	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2022
1	Uric Acid (Urate)IBA 05/2021
1	Insulin (Novolin)FDA Link 05/2021
1	Glucagon-Like Peptide-1 Receptor AgonistsIBA 01/2021
1	Type 1 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 1)IBA 05/2017
1	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 05/2017
1	dactolisibIBA 01/2017
1	LDL Lipoproteins (beta Lipoproteins)IBA 12/2015
1	LipidsIBA 01/2014
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2014
1	Vitamin D FDA LinkGeneric 01/2014
1	Sterol Regulatory Element Binding ProteinsIBA 01/2014
1	Liver X ReceptorsIBA 01/2014
1	hydroxide ionIBA 01/2014
1	Acarbose FDA LinkGeneric 12/2013
1	Hormones (Hormone)IBA 12/2013

Therapy/Procedure

4	Therapeutics 01/2023 - 01/2014
1	Glycemic Control 10/2023
1	Gastrectomy 12/2013
1	Bariatric Surgery 12/2013